Paper1011990
Fibrin-stabilizing factor (factor XIII).
Curtis CG and 1 other. Methods Enzymol, 1976. Cited by 58 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Fibrin-stabilizing factor (factor XIII). Papers, record 1011990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1011990
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Factor XIII | Major topic |
| Animals | |
| Cations, Divalent | |
| Enzyme Activation | |
| Fibrin | |
| Fluorescent Dyes | |
| Macromolecular Substances | |
| Methods | |
| Molecular Weight | |
| Spectrometry, Fluorescence |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 10,377,424 | Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10377424 | PubMed |
| 7,430,249 | Fibronectin-mediated uptake of gelatin-coated latex particles by peritoneal macrophages. | J Cell Biol | 1980 | https://conductscience.org/library/papers/7430249 | PubMed |
| 7,199,538 | Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7199538 | PubMed |
| 6,889,599 | Ultrastructure of clots during isometric contraction. | J Cell Biol | 1982 | https://conductscience.org/library/papers/6889599 | PubMed |
| 6,886,002 | "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6886002 | PubMed |
| 6,853,717 | Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6853717 | PubMed |
| 6,376,109 | Biochemical and cellular mechanisms of dust-induced lung fibrosis. | Environ Health Perspect | 1984 | https://conductscience.org/library/papers/6376109 | PubMed |
| 6,143,256 | Transglutaminases. | Mol Cell Biochem | 1984 | https://conductscience.org/library/papers/6143256 | PubMed |
| 3,422,419 | Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3422419 | PubMed |
| 2,888,718 | Isolation of a polymorphic genomic clone from chromosome 7. Physical and genetic linkage studies to markers around the cystic fibrosis locus. | Hum Genet | 1987 | https://conductscience.org/library/papers/2888718 | PubMed |
| 2,877,457 | Characterization of cDNA coding for human factor XIIIa. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/2877457 | PubMed |
| 2,860,124 | Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. | J Clin Invest | 1985 | https://conductscience.org/library/papers/2860124 | PubMed |
| 2,440,424 | The conformational changes of alpha 2-macroglobulin induced by methylamine or trypsin. Characterization by extrinsic and intrinsic spectroscopic probes. | Biochem J | 1987 | https://conductscience.org/library/papers/2440424 | PubMed |
| 2,419,360 | Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis. | J Clin Invest | 1986 | https://conductscience.org/library/papers/2419360 | PubMed |
| 1,978,326 | Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/1978326 | PubMed |
| 279,911 | Ca2+-related regulatory function of fibrinogen. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/279911 | PubMed |
| 96,136 | Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder. | J Clin Invest | 1978 | https://conductscience.org/library/papers/96136 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| F13A1 | 2,162 | PubTator's text mining | https://conductscience.org/library/genes/2162 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1011990
GET https://conductscience.org/api/papers/v1/1011990/authors